These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Treatment of polymorphous light eruptions with beta-carotene. Swanbeck G; Wennersten G Acta Derm Venereol; 1972; 52(6):462-6. PubMed ID: 4118392 [No Abstract] [Full Text] [Related]
27. Erythropoietic protoporphyria. Report of a case successfully treated with carotene. Chapel TA; Stewart RH; Webster SB Arch Dermatol; 1972 Apr; 105(4):572-3. PubMed ID: 5017268 [No Abstract] [Full Text] [Related]
28. The quality of life of 790 patients with photodermatoses. Jong CT; Finlay AY; Pearse AD; Kerr AC; Ferguson J; Benton EC; Hawk JL; Sarkany RP; McMullen E; Rhodes LE; Farr PM; Anstey AV Br J Dermatol; 2008 Jul; 159(1):192-7. PubMed ID: 18460025 [TBL] [Abstract][Full Text] [Related]
29. Variable effects of beta-carotene therapy in a child with erythropoietic protoporphyria. Alemzadeh R; Feehan T Eur J Pediatr; 2004 Sep; 163(9):547-9. PubMed ID: 15241683 [TBL] [Abstract][Full Text] [Related]
30. Photosensitivity: results of investigation in 250 patients. Wasserman GA; Haberman HF Can Med Assoc J; 1975 Dec; 113(11-12):1055-60. PubMed ID: 1201541 [TBL] [Abstract][Full Text] [Related]
31. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284 [TBL] [Abstract][Full Text] [Related]
32. Carotenoid treatment for light sensitivity: a reappraisal and six years' experience. Wennersten G Acta Derm Venereol; 1980; 60(3):251-5. PubMed ID: 6158229 [TBL] [Abstract][Full Text] [Related]
33. -Carotene as a treatment for photohypersensitivity due to erythropoietic protoporphyria. Baart de la Faille H; Suurmond D; Went LN; van Steveninck J; Schothorst AA Dermatologica; 1972; 145(6):389-94. PubMed ID: 4657758 [No Abstract] [Full Text] [Related]
34. Letter: Etiology of erythropoietic protoporphyria, and protection of photosensitive subjects. Fusaro RM; Johnson JA Acta Derm Venereol; 1974; 54(6):501-2. PubMed ID: 4140668 [No Abstract] [Full Text] [Related]
35. Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption. Parrish JA; Le Vine MJ; Morison WL; Gonzalez E; Fitzpatrick TB Br J Dermatol; 1979 Feb; 100(2):187-91. PubMed ID: 427019 [TBL] [Abstract][Full Text] [Related]
36. [B-carotene as the therapeutic agent for erythropoetic protoporphyria, not the last resort]. Kuhlwein A; Beykirch W Z Hautkr; 1980 Jun; 55(12):817-23. PubMed ID: 7415363 [No Abstract] [Full Text] [Related]
39. Beta-carotene content of certain organs from two patients receiving high doses of beta-carotene. Mathews-Roth MM; Abraham AA; Gabuzda TG Clin Chem; 1976 Jun; 22(6):922-4. PubMed ID: 1277485 [TBL] [Abstract][Full Text] [Related]
40. [The management of a case of congenital erythropoetic prophyria (author's transl)]. Jung EG Dtsch Med Wochenschr; 1977 Feb; 102(8):279-80. PubMed ID: 837847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]